General Biological Corporation operates in the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares General Biological with three other
companies in this sector in Taiwan:
Holy Stone Healthcare Co Ltd
sales of 132.84 million Taiwanese Dollars [US$4.37 million]
Orient Pharma Co Ltd
(274.38 million Taiwanese Dollars [US$9.03 million]
of which 43%
was Pant Operation-Medicine Foundry and Pack), and
Taiwan Advance Bio-Pharmaceutical Inc
(120.10 million Taiwanese Dollars [US$3.95 million]
General Biological reported sales of 184.55 million Taiwanese Dollars (US$6.07 million)
December of 2016.
increase of 10.0%
versus 2015, when the company's sales were 167.80 million Taiwanese Dollars.
Despite this increase, sales are still
below the level achieved in 2014, when General Biological
reported sales of 198.54 million Taiwanese Dollars.
The sales level in 2016 was fairly close to the level five years ago: in 2011, General Biological had sales
of 171.43 million Taiwanese Dollars.
Sales of Testing Drug-Testing saw an increase
14.3% in 2016, from
71.62 million Taiwanese Dollars to 81.83 million Taiwanese Dollars.